|
顯示項目 192921-192930 / 2348971 (共234898頁)
<< < 19288 19289 19290 19291 19292 19293 19294 19295 19296 19297 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-07-26T10:04:00Z |
Antimicrobial actions and applications of Chitosan
|
Ke C.-L;Deng F.-S;Chuang C.-Y;Lin C.-H.; Ke C.-L; Deng F.-S; Chuang C.-Y; Lin C.-H.; CHING-HSUAN LIN |
| 中國醫藥大學 |
2009-11 |
Antimicrobial Activities and Cellular Responses to Natural Silicate Clays and Derivatives Modified by Cationic Alkylamine Derivatives Modified by Cationic Alkylamine
|
徐善慧(Shan-hui Hsu);曾向榮(Hsiang-Jung Tseng);洪慧珊(Huey-Shan Hung);王明鍵(Ming-Chien Wang);洪瓊慧(Chiung-Hui Hung);李珮如(Pei-Ru Li);林江珍(Jiang-Jen Lin)* |
| 臺大學術典藏 |
2018-09-10T07:26:47Z |
Antimicrobial activities and cellular responses to natural silicate clays and derivatives modified by cationic alkylamine salts
|
Hsu, S.-H.; Tseng, H.-J.; Hung, H.-S.; Wang, M.-C.; Hung, C.-H.; Li, P.-R.; Lin, J.-J.; SHAN-HUI HSU; JIANG-JEN LIN |
| 臺大學術典藏 |
2018-09-10T15:37:07Z |
Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
|
Chiang, T.-T. and Tang, H.-J. and Chiu, C.-H. and Chen, T.-L. and Ho, M.-W. and Lee, C.-H. and Sheng, W.-H. and Yang, Y.-S.; WANG-HUEI SHENG |
| 臺大學術典藏 |
2021-02-26T01:59:32Z |
Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
|
Chiang T.-T.;Tang H.-J.;Chiu C.-H.;Chen T.-L.;Ho M.-W.;Lee C.-H.;Wang-Huei Sheng;Yang Y.-S.; Chiang T.-T.; Tang H.-J.; Chiu C.-H.; Chen T.-L.; Ho M.-W.; Lee C.-H.; WANG-HUEI SHENG; Yang Y.-S. |
| 國立成功大學 |
2019 |
Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against escherichia coli, klebsiella pneumoniae, and pseudomonas aeruginosa isolated from intensive care units in Taiwan: Results from the surveillance of multicen
|
Liao, C.-H.;Lee, N.-Y.;Tang, H.-J.;Lee, S.S.J.;Lin, C.-F.;Lu, P.-L.;Wu, J.-J.;Ko, W.-C.;Lee, W.-S.;Hsueh, P.-R. |
| 嘉南藥理大學 |
2019 |
Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
|
Liao, Chun-Hsing; Lee, Na-Yao; Tang, Hung-Jen; Lee, Susan Shin-Jung; Lin, Chin-Fu; Lu, Po-Liang; Wu, Jiunn-Jong; Ko, Wen-Chien; Lee, Wen-Sen; Hsueh, Po-Ren |
| 臺大學術典藏 |
2020-03-27T05:28:28Z |
Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against escherichia coli, klebsiella pneumoniae, and pseudomonas aeruginosa isolated from intensive care units in Taiwan: Results from the surveillance of multicenter antimicrobial resistance in Taiwan in 2016
|
PO-REN HSUEH; Lee W.-S.; Ko W.-C.; Wu J.-J.; Lu P.-L.; Lin C.-F.; PO-REN HSUEH;Lee W.-S.;Ko W.-C.;Wu J.-J.;Lu P.-L.;Lin C.-F.;Lee S.S.J.;Tang H.-J.;Lee N.-Y.;Liao C.-H.; Liao C.-H.; Lee N.-Y.; Tang H.-J.; Lee S.S.J. |
| 臺大學術典藏 |
2020-12-18T08:37:03Z |
Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against escherichia coli, klebsiella pneumoniae, and pseudomonas aeruginosa isolated from intensive care units in Taiwan: Results from the surveillance of multicenter antimicrobial resistance in Taiwan in 2016
|
PO-REN HSUEH; Lee W.-S.; Ko W.-C.; Wu J.-J.; Lu P.-L.; Lin C.-F.; Lee S.S.J.; Tang H.-J.; Lee N.-Y.; Liao C.-H.; Liao C.-H.;Lee N.-Y.;Tang H.-J.;Lee S.S.J.;Lin C.-F.;Lu P.-L.;Wu J.-J.;Ko W.-C.;Lee W.-S.;Po-Ren Hsueh |
| 中國醫藥大學 |
2014-08-23 |
Antimicrobial activities of glycyrrhizic acid and glycyrrhetinic acid in vitro
|
(Wei-Han Huang);徐媛曼(Yuan-Man Hsu)* |
顯示項目 192921-192930 / 2348971 (共234898頁)
<< < 19288 19289 19290 19291 19292 19293 19294 19295 19296 19297 > >>
每頁顯示[10|25|50]項目
|
